Impact of diabetes on platelet activation in different manifestations of atherosclerosis
BACKGROUND: Atherosclerosis affects many patients with type 2 diabetes. Both are associated with platelet activation, but it remains unclear how diabetes contributes to, or even enhances, platelet activation in patients with atherosclerosis. We therefore investigated the impact of diabetes on...
Main Authors: | Thomas Gremmel, Christoph W Kopp, Daniela Seidinger, Renate Koppensteiner, Sabine Steiner, Simon Panzer |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2013-05-01
|
Series: | Swiss Medical Weekly |
Subjects: | |
Online Access: | https://www.smw.ch/index.php/smw/article/view/1691 |
Similar Items
-
Impaired glucose metabolism is associated with increased thrombin generation potential in patients undergoing angioplasty and stenting
by: Silvia Lee, et al.
Published: (2018-09-01) -
Interleukin-6 and asymmetric dimethylarginine are associated with platelet activation after percutaneous angioplasty with stent implantation.
by: Thomas Gremmel, et al.
Published: (2015-01-01) -
Thrombin-induced platelet aggregation −effect of dabigatran using automated platelet aggregometry−
by: Mie Shimizu, et al.
Published: (2020-04-01) -
Regression of Atherosclerosis in ApoE−/− Mice Via Modulation of Monocyte Recruitment and Phenotype, Induced by Weekly Dosing of a Novel “Cytotopic” Anti‐Thrombin Without Prolonged Anticoagulation
by: Daxin Chen, et al.
Published: (2020-07-01) -
A hypothesis-generating study to evaluate platelet activity in diabetics with chronic kidney disease
by: Martin rika J, et al.
Published: (2005-03-01)